Healthcare Realty Trust (NYSE:HR – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.560-1.600 for the period, compared to the consensus earnings per share estimate of 1.590. The company issued revenue guidance of -.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. JPMorgan Chase & Co. cut shares of Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 price target on the stock. in a research report on Friday, December 20th. Wedbush cut shares of Healthcare Realty Trust from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $18.00 to $16.00 in a report on Thursday, January 2nd. Finally, Jefferies Financial Group cut shares of Healthcare Realty Trust from a “buy” rating to a “hold” rating and cut their price objective for the stock from $19.00 to $17.00 in a report on Thursday, January 2nd. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $17.00.
View Our Latest Research Report on Healthcare Realty Trust
Healthcare Realty Trust Stock Performance
Healthcare Realty Trust (NYSE:HR – Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01. Healthcare Realty Trust had a negative net margin of 45.63% and a negative return on equity of 9.42%. As a group, equities analysts expect that Healthcare Realty Trust will post 1.55 earnings per share for the current fiscal year.
Insider Activity
In related news, COO Robert E. Hull sold 10,000 shares of the stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $17.48, for a total transaction of $174,800.00. Following the transaction, the chief operating officer now owns 171,400 shares in the company, valued at $2,996,072. This represents a 5.51 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Thomas N. Bohjalian acquired 7,750 shares of the stock in a transaction that occurred on Friday, November 22nd. The shares were bought at an average price of $17.39 per share, for a total transaction of $134,772.50. Following the transaction, the director now owns 50,002 shares of the company’s stock, valued at $869,534.78. This trade represents a 18.34 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought a total of 18,750 shares of company stock worth $323,723 over the last 90 days. 0.56% of the stock is currently owned by insiders.
Healthcare Realty Trust Company Profile
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
See Also
- Five stocks we like better than Healthcare Realty Trust
- How to Find Undervalued Stocks
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- What Are Growth Stocks and Investing in Them
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- What is a Death Cross in Stocks?
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.